| Medical and Health Sciences | 2021-2025 | 88 | GB 9 | 99.98 |
| Nephrology | Lifetime | 75 | GB 4 | 99.48 |
| Hematology | Lifetime | 530 | GB 44 | 96.24 |
| Nephrology | 2021-2025 | 2 | GB 1 | 99.94 |
| Immunology | 2021-2025 | 51 | GB 3 | 98.96 |
| Hematology | 2021-2025 | 25 | GB 1 | 99.47 |
| Pathology and Forensic Medicine | 2021-2025 | 134 | GB 7 | 96.91 |
| Rheumatology | 2021-2025 | 339 | GB 27 | 87.59 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 905 | GB 53 | 87.64 |
| Renal Diseases and Glomerulopathies | Lifetime | 63 | GB 4 | 99.50 |
| Autoimmune Bullous Skin Diseases | Lifetime | 59 | GB 7 | 99.24 |
| Platelet Disorders and Treatments | Lifetime | 98 | GB 7 | 99.07 |
| Complement system in diseases | Lifetime | 124 | GB 16 | 98.42 |
| Chronic Kidney Disease and Diabetes | Lifetime | 186 | GB 5 | 98.89 |
| Vasculitis and related conditions | Lifetime | 177 | GB 14 | 97.93 |
| Erythropoietin and Anemia Treatment | Lifetime | 393 | GB 28 | 94.52 |
| Celiac Disease Research and Management | Lifetime | 607 | GB 65 | 93.30 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 1 | GB 1 | 99.95 |
| Platelet Disorders and Treatments | 2021-2025 | 1 | GB 1 | 99.91 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 2 | GB 1 | 99.85 |
| Complement system in diseases | 2021-2025 | 1 | GB 1 | 99.92 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 8 | GB 1 | 99.70 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 60 | GB 5 | 98.72 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 14 | GB 2 | 98.22 |
| Blood groups and transfusion | 2021-2025 | 56 | GB 6 | 96.55 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 258 | GB 19 | 97.15 |
| Dialysis and Renal Disease Management | 2021-2025 | 220 | GB 28 | 95.59 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 214 | GB 15 | 93.49 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 129 | GB 7 | 93.51 |
| Vasculitis and related conditions | 2021-2025 | 184 | GB 16 | 93.86 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 409 | GB 23 | 90.49 |
| Mast cells and histamine | 2021-2025 | 214 | GB 10 | 85.51 |
| Pregnancy and Medication Impact | 2021-2025 | 408 | GB 34 | 83.94 |
| Health and Medical Research Impacts | 2021-2025 | 514 | GB 37 | 71.78 |
| Celiac Disease Research and Management | 2021-2025 | 604 | GB 34 | 71.44 |
| Blood transfusion and management | 2021-2025 | 659 | GB 42 | 65.98 |
| Renin-Angiotensin System Studies | 2021-2025 | 621 | GB 22 | 43.41 |
